During the last session, Viridian Therapeutics Inc (NASDAQ:VRDN)’s traded shares were 0.66 million, with the beta value of the company hitting 0.47. At the end of the trading day, the stock’s price was $12.39, reflecting an intraday loss of -3.05% or -$0.39. The 52-week high for the VRDN share is $27.20, that puts it down -119.53 from that peak though still a striking 20.1% gain since the share price plummeted to a 52-week low of $9.90. The company’s market capitalization is $1.01B, and the average trade volume was 924.47K shares over the past three months.
Viridian Therapeutics Inc (VRDN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.24. VRDN has a Sell rating from 0 analyst(s) out of 11 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 10 recommend a Buy rating for it.
Viridian Therapeutics Inc (NASDAQ:VRDN) trade information
Viridian Therapeutics Inc (VRDN) registered a -3.05% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -3.05% in intraday trading to $12.39, hitting a weekly high. The stock’s 5-day price performance is -9.03%, and it has moved by 5.09% in 30 days. Based on these gigs, the overall price performance for the year is -18.16%.
The consensus price target of analysts on Wall Street is $20.5, which implies an increase of 39.56% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.5 and $20.5 respectively. As a result, VRDN is trading at a discount of -65.46% off the target high and -65.46% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 31.28%. While earnings are projected to return -8.15% in 2025, the next five years will return 18.32% per annum.
VRDN Dividends
Viridian Therapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 4.77 million shares, is of BLACKROCK INC.’s that is approximately 7.4758% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $62.1 million.
Also, the Mutual Funds coming in first place with the largest holdings of Viridian Therapeutics Inc (VRDN) shares are Fidelity Select Portfolios-Health Care Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Mar 31, 2025 indicates that Fidelity Select Portfolios-Health Care Portfolio owns about 2.44 shares. This amounts to just over 2.99 percent of the company’s overall shares, with a $30.18 million market value. The same data shows that the other fund manager holds slightly less at 2.22, or about 2.72% of the stock, which is worth about $27.5 million.
